2419-67-2

Basic information

• Product Name: 1-(4-Methoxyphenyl)-4,4-dimethyl-1-penten-3-one
• Synonyms: 1-(4-Methoxyphenyl)-4,4-dimethyl-1-penten-3-one
• CAS NO: 2419-67-2
• Molecular Formula: C₁₄H₁₈O₂
• Molecular Weight: 218.2915
• Mol File: 2419-67-2.mol
• Article Data: 17

Chemical Properties

• Boiling Point: 348.3°Cat760mmHg
• Flash Point: 149.7°C
• Appearance: /
• Density: 1.003g/cm³
• Vapor Pressure: 5.09E-05mmHg at 25°C
• Refractive Index: 1.531
• CAS DataBase Reference: 1-(4-Methoxyphenyl)-4,4-dimethyl-1-penten-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-Methoxyphenyl)-4,4-dimethyl-1-penten-3-one(2419-67-2)
• EPA Substance Registry System: 1-(4-Methoxyphenyl)-4,4-dimethyl-1-penten-3-one(2419-67-2)

Safety Data

• Hazardous Substances Data: 2419-67-2(Hazardous Substances Data)

Usage

InChI:InChI=1/C14H18O2/c1-14(2,3)13(15)10-7-11-5-8-12(16-4)9-6-11/h5-10H,1-4H3/b10-7+

Upstream product

• 17510-46-2 3,3-dimethyl-2-(trimethylsilyl)oxy-1-butene 
• 123-11-5 4-methoxy-benzaldehyde 
• 75-97-8 3,3-dimethyl-butan-2-one 
• 1576-35-8 toluene-4-sulfonic acid hydrazide 
• 3900-79-6 toluene-4-sulfonic acid isopropylidenehydrazide 

Downstream Products

• 7475-25-4 (1RS,2SR)-1,2-dibromo-1-(4-methoxy-phenyl)-4,4-dimethyl-pentan-3-one 
• 97792-22-8 5-(4-Methoxy-phenyl)-2,2,8,8-tetramethyl-nonane-3,7-dione 
• 201804-19-5 1-((2R,3S)-4-methoxyphenyloxiranyl)-2,2-dimethylpropan-1-one 
• 106272-68-8 3-(tert-butyl)-5-(4-methoxyphenyl)isoxazole 
• 101499-19-8 1ξ-methoxy-1-(4-methoxy-phenyl)-4,4-dimethyl-pent-1-en-3-one 
• 1028801-22-0 1-(4-methoxyphenyl)-4,4-dimethyl-1-penten-3-one oxime 
• 1400633-21-7 4-(3-(tert-butyl)-5-(4-methoxyphenyl)-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid 
• 100789-95-5 1-(4-methoxyphenyl)-4,4-dimethylpentan-3-one 

Relevant articles and documents

Decarboxylation-triggered homo-Nazarov cyclization of cyclic enol carbonates catalyzed by rhenium complex

Decarboxylative homo-Nazarov cyclization catalyzed by a Lewis acid was achieved using a cyclic enol carbonate bearing a cyclopropane moiety as a substrate. Various substrates were converted into the corresponding multi-substituted cyclohexenones in good yieldsviadecarboxylation, followed by 6-membered ring formation involving cyclopropane-ring-opening.

From Celecoxib to a Novel Class of Phosphodiesterase 5 Inhibitors: Trisubstituted Pyrazolines as Novel Phosphodiesterase 5 Inhibitors with Extremely High Potency and Phosphodiesterase Isozyme Selectivity

A ligand-based approach involving systematic modifications of a trisubstituted pyrazoline scaffold derived from the COX2 inhibitor, celecoxib, was used to develop novel PDE5 inhibitors. Novel pyrazolines were identified with potent PDE5 inhibitory activit

ALLOSTERIC INHIBITORS OF ATYPICAL PROTEIN KINASES C

The invention provides specific small molecule compounds that allosterically regulate the activity of atypical protein kinase C, their use as a medicament, and their use in the treatment and prevention of allergic, inflammatory and autoimmune disorders, cancer, hyperproliferation, sepsis, viral and protozoan infections, dementing diseases, metabolic, sclerotic and osteoporotic disorders.